Introduction
C-reactive protein (CRP) is a systemic inflammation marker that predicts future cardiovascular risk. [1] [2] [3] Plasma CRP levels increase with age and are higher in women than in men. [4] [5] [6] [7] [8] [9] African American (AA) and Hispanic American (HA) individuals have higher concentrations of CRP than do European American (EA) individuals. [4] [5] [6] [7] [8] [9] Chronic low-grade inflammation might contribute to increased cardiovascular disease risk and other health disparities among these minority United States populations. 10 CRP levels are also correlated with obesity and other metabolic and atherosclerotic risk factors. [11] [12] [13] The correlation between CRP and adiposity does not appear to completely explain the higher CRP levels in populations of African descent. [12] [13] [14] [15] Therefore, other factors, both genetic and nongenetic, most likely contribute to CRP differences between racial and ethnic groups.
Family and twin studies suggest that additive genetic factors account for 25%-40% of the variance in plasma CRP levels in Europeans [16] [17] [18] and 45% in AA individuals. 19 Recent large genome-wide association studies (GWASs) conducted on Europeans and Japanese have identified approximately 20 CRP-associated loci that together explain~5% of the variance. [20] [21] [22] [23] No large CRP GWAS performed to date has included participants of African or Hispanic ancestry. Recently, a GWAS was performed on~800 AA individuals, but no new loci were discovered. 24 Using genotype and phenotype data from the Women's Health Initiative SNP Health Association Resource (WHI-SHARe), we therefore undertook a GWAS and local-ancestry analysis of 8,280 AA participants and a GWAS of 3,548 HA participants. Our goals were to identify new and possibly ancestry-specific genetic variants associated with CRP in AA and HA women and to assess the genetic architecture of CRP association in these women at inflammatory and metabolism loci previously identified in CRP GWASs of European and Asian populations.
Subjects and Methods
Our overall approach can be summarized as follows. (1) The GWAS discovery stage consisted of 8,280 WHI-SHARe AA samples and 3,548 HA samples and also included admixture mapping of the AA population. Because of issues related to heterogeneous ethnicity within Latinos, 25 the lack of availability of an adequately-sized Native American reference panel (which impacts estimation accuracy), and the smaller Women's Health Initiative (WHI) HA sample size (compared to the larger AA sample), we did not perform admixture mapping in the HA sample. (2) Validation of the CRP-associated locus, as well as functional validation with expression quantitative trait locus (eQTL) analysis, was performed for independent cohorts including Candidate Gene Association Resource (CARe) AA individuals (n ¼ 6,300) and whites from the Atherosclerosis Risk in Communities (ARIC) study (n ¼ 5,656 
CRP Measurement
High-sensitivity CRP was measured in serum from a total of 11,962 WHI-SHARe participants on a Roche Modular P Chemistry analyzer at the University of Minnesota with the use of a latex-particle enhanced immunoturbidimetric assay kit (Roche Diagnostics, Indianapolis, IN) The results were reported in mg/l. Median CRP was 3.50 and the interquartile range was 1.58-7.40. The assay coefficient of variation was 2.3%. All CRP values were natural-log transformed for normalizing the distributions of the phenotypic data.
Genotyping and Quality Control
Genome-wide genotyping was performed at Affymetrix on the Affymetrix 6.0 array with 2 mg of DNA at a concentration of 100 ng/ml. Approximately 1% (n ¼ 99) of samples could not be genotyped. We excluded samples that had a call rate below 95% (n ¼ 16), that were duplicates of subjects other than monozygotic twins (n ¼ 34), or that had a Y chromosome (n ¼ 1). SNPs on the Y chromosome and Affymetrix quality-control (QC) probes were excluded from analysis (n ¼ 3,280). We also flagged SNPs that had call rates, calculated separately for AA and HA individuals, < 95% and concordance rates < 98%, leaving 871,309 unflagged SNPs. After exclusions, there were 12,007 unique subjects (8, 421 AA and 3,586 HA), and there was an average call rate of 99.8% over the unflagged SNPs. We analyzed 188 pairs of blind duplicate samples. The overall concordance rate was 99.8% (the ranges were 94.5%-100% over samples, 98.3%-100% over samples with call rates > 98%, and 98.1%-100% over unflagged SNPs).
Genotype Imputation
Imputation was carried out with MaCH. 27 After some more strin- 
Relatedness
We used a random subset of 100,000 SNPs from autosomal chromosomes and the method-of-moments approach to a threeparameter identity-by-descent (IBD) model 28 to compute IBD coefficients between all pairs of 12,008 subjects. On the basis of these coefficients, we identified pairs of parents and offspring (22 pairs and 2 trios), monozygotic twins (five pairs), and siblings (192 pairs and 5 trios). A more thorough confirmatory analysis with a pairwise kinship-coefficient estimator, 29 as well as the aforementioned method-of-moments approach, was performed separately for AA and HA individuals, and it validated these relationships and identified half siblings (73 pairs). In CRP association analyses, we included one individual from each relative pair, typically the one with the higher call rate.
Admixture Estimation and Principal-Component Analysis
Separately for the AA and the HA samples, we computed eigenvectors by using Eigenstrat 30 at 178,101 markers that were in common between our samples and the reference panels. We also determined individual ancestral proportions by using Frappe 31 at 656,852 autosomal markers. For both of these calculations, we included 475 publically available samples from ancestral populations (YRI, CEU, East Asians, and Native Americans). 32, 33 On the basis of the Frappe estimates, we identified 56 subjects who were self-identified as AA but who appeared to have less than 10% African ancestry. We also flagged one participant with questionable estimates of both ancestry and relatedness. Because we cannot exclude the possibility of either a sample mishandling or a data-entry error, we flagged these 57 samples for exclusion.
Local-Ancestry Estimation
For each AA individual in the sample, locus-specific ancestry (the probability of whether an individual has 0, 1, or 2 alleles of African ancestry at each locus) was estimated with the program SABERþ,
an extension of the model described in Tang et al. 34 In brief, SABERþ uses a graphical-model approach to adaptively capture local haplotype structure within each ancestral population and thereby more accurately accounts for background linkage disequilibrium (LD). In simulation studies, this method compares favorably to existing methods in terms of the accuracy and computational efficiency; its error rate is less than 1.5%. In the current analysis, phased haplotype data from the HapMap3 CEU and YRI individuals were augmented as the reference panels. In simulation studies, SABERþ achieves accuracy similar to that of HapMix; based on analysis of simulated and real AA genotypes, the correlation between local-ancestry estimates produced by the two methods is very high.
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GWAS Data Analysis
GWASs for ln-transformed CRP (excluding the WHI-SHARe study participants with raw CRP values > 100 mg/dl) were performed under an additive genetic model with the use of covariate-adjusted linear regression implemented in either PLINK v.1.07 28 or MACH2QTL v.1.08. 27 Analyses were conducted separately for self-identified AA and HA individuals. For direct or imputed genotypes, allelic dosage at each SNP was used as the independent variable, adjusted for primary covariates of age and geographic region. In sensitivity analyses, we additionally adjusted for body mass index (BMI), hormone therapy, diabetes, and hypertension.
To adjust for population stratification and global admixture, we also incorporated the first four principal components (PCs) as covariates in the regression models. Eigenvectors 5-10 showed no evidence of association with CRP levels. To maintain an overall type 1 error rate of 5%, we used a threshold of a ¼ 2.5 3 10 À8 to declare genome-wide statistical significance. This threshold has been suggested for African ancestry populations on the basis of estimates of approximately two million independent commonvariant tests in African genomes. 36 To further assess the potential existence of multiple, independent variants influencing a trait at the same locus (allelic heterogeneity), we repeated regression analyses, conditional on the most strongly associated (index) SNP in that region. To assess in the WHI-SHARe AA and HA individuals trait-associated loci previously reported in Europeans or Japanese, we evaluated the AA and HA results (including consistency of direction of effect) for each index SNP in the regions reported and assessed statistical significance by a simple Bonferroni adjustment based on the total number of SNPs assessed with a two-sided hypothesis test.
Admixture Mapping
Using the local-ancestry estimates, we performed an admixturemapping analysis to detect variants that are present at different frequencies among the European and African ancestral populations. Adjusting for age and genome-wide ancestry proportions by using the first four PCs, we regressed ln-CRP on locus-specific ancestry. We performed the admixture scan with and without additional adjustment for BMI. The critical value for genomewide significance level of admixture mapping is substantially lower than that for the genotype test because the recent history of admixture gives rise to extensive correlation in local ancestry. On the basis of previous theoretical analysis and simulation results, a nominal p value of 7 3 10 À6 yielded a genome-wide type I error of 0.05. 34 
Validation of New CRP Association Signals in Independent Samples
Replication of novel association findings in WHI AA individuals was performed with GWAS data from 3,548 HA women from WHI-SHARe, 6,300 AA men and women from the CARe consortium, and 5,656 whites from the ARIC study. Both genotyped and imputed SNP data were available in the CARe AA, WHI-SHARe HA, and ARIC white samples. We used a p value of < 0.05 to declare statistical significance in the replication samples. We conducted meta-analyses combining data from our discovery and replication cohorts by using inverse-variance weighted fixed-effects models to combine beta coefficients and standard errors from study-level regression results for each SNP to derive effect estimates and a combined p value. Meta-analyses were implemented in the software METAL. 37 
Analysis of eQTLs
We assessed the functional effects of newly identified CRP-associated SNPs on gene expression by querying a publically accessible database containing genome-wide analysis of 22,305 genes expressed in peripheral-blood monocytes of 1,467 European individuals. 38 
Results
Assessment of Global and Local Ancestry in Relation to CRP in Admixed Populations
WHI participant characteristics are summarized by selfreported ethnicity in Table 1 . Among AA individuals, mean estimates of genome-wide ancestry proportions were 76% African, 21% European, <2% Asian, and <2% Native American. Among HA participants, the mean estimates were 60% European, 32% Native American, 6% African, and <2% East Asian. European ancestry was Figure S1 , available online. The lead or index SNPs associated with the CRP phenotype in each genomic region are summarized in Tables 2 and 3 
Assessment of Allelic Heterogeneity at the CRP Locus
The magnitude and breadth of the CRP association signal spanning chromosomal region 1q23 in both the admixture scan and GWAS suggest the possibility of allelic heterogeneity at this locus. We therefore performed a series of conditional analyses in which we initially adjusted for the index SNP rs16827466 and then successively adjusted the CRP association signal for the most strongly associated SNP remaining at each step. As shown in Table 4 , there was evidence of at least three independent CRP-associated alleles. The African-ancestry-specific rs16827466 T allele is associated with higher CRP and appears to account for 50% of the local-ancestry association signal in this region. rs7553007 and rs2808634 are associated with lower CRP, and the CRP-lowering alleles at each SNP are more common in European populations than in African populations. After a simultaneous adjustment for rs16827466, rs7553007, and rs2808634, the p value for association between local ancestry and CRP is 0.047. Therefore, these three CRP variants appear to account for much, but perhaps not all, of local-ancestry association signal in chromosomal region 1q23. 
À6 (under the assumption of 7,000 independent tests). There is one strongly genome-wide significant peak centered around CRP on chromosome 1, indicating that local African ancestry in this region is associated with CRP. Interestingly, local African ancestry in chromosomal region 1q23 is also strongly associated with lower white blood cell count (WBC) (another inflammation-sensitive phenotype) in African Americans as a result of a common African-ancestry-specific null DARC (MIM 613665) variant, FY*O (rs2814778). In a recent GWAS from Sardinia, 20 DARC rs3845624 was reported to be independently associated with CRP. In the initial WHI AA GWAS, rs3845624 (MAF ¼ 0.15; imputation R 2 ¼ 0.94) was nominally associated with CRP (p ¼ 2 3 10 À7 ). However, in the conditional GWAS (with an adjustment for the three independently associated CRP variants rs16827466, rs7553007, and rs2808634), the p value for this SNP was 0.30. Because of the correlation between CRP and WBC (which accounts for~5% of CRP phenotypic variation), we repeated the CRP association analysis in AA individuals by adjusting for WBC. The FY*O allele at DARC showed statistically significant association (when we adjusted for both the three CRP SNPs and WBC; p ¼ 2.4 3 10 À30 ).
However, upon adjustment for local ancestry at CRP, the association disappeared. We emphasize that these results do not exclude the DARC locus as a functional locus but rather are constrained by the population genetic structure. The apparent association between the FY*O allele and CRP level might represent functional involvement of DARC, or FY*O might simply tag additional undiscovered CRPassociated variants in chromosomal region 1q23. In AA individuals, admixture generates strong LD between DARC and CRP; therefore, it is difficult to statistically disentangle the contribution of the two loci.
To assess allelic heterogeneity at additional CRP-associated loci, we repeated the GWAS in AA individuals by conditioning on all eight independent, genome-wide significant CRP-associated SNPs (three from CRP, one from LEPR, one from IL1RN, one from TREM2, one from HNF1A, and one from APOE). There were no additional association signals.
Discovery and Validation of the CRP-Associated Locus in Chromosomal Region 6p21
Of the six genomic regions significantly associated with CRP in either AA or HA individuals or both, only chromosomal region 6p21 has not been previously associated with CRP in any population. The CRP signal in this region is located within a cluster of genes that encode the triggering receptors expressed by myeloid cells (TREM) family of leukocyte receptors, which are involved in the regulation of proinflammatory cytokines and chemokine production by neutrophils, monocytes, macrophages, and dendritic cells. The index SNP rs7748513 is located within the second intron of TREM2. The rs7748513 variant G allele associated with higher CRP is common in AA individuals (MAF ¼ 0.43) but is much less common in other populations (MAF < 0.05 in HapMap European and Asian populations). Additional adjustment for local African ancestry did not alter the association between TREM2 rs7748513 and CRP (beta ¼ 0.102 5 0.020; p ¼ 3.8 3 10 À7 ).
When stratified by local ancestry and adjusted for global ancestry, the association between rs7748513 and CRP was present in the 7,722 AA individuals who carried two (beta ¼ 0.100 5 0.0232; p < 0.0001) or one (beta ¼ 0.122 5 0.041; p < 0.0001) African chromosomes at the TREM2 locus, but not in the 557 AA individuals who carried two European chromosomes (beta ¼ À0.222 5 0.190; p ¼ 0.25). However, not surprisingly, the MAF of rs7748513 is considerably lower (0.04) among those women carrying two European chromosomes at this locus; therefore, there is limited power for detecting an association in this stratum. No other SNPs in the TREM cluster reached genomewide significance in AA individuals. However, another African-ancestry-specific coding variant of TREM2, rs2234253 (MAF ¼ 0.11), was associated with 0.12 5 0.023 higher ln-CRP (p ¼ 3 3 10 À5 ). Within TREM2 exon 2, rs2234253 encodes a p.Thr96Lys substitution that is predicted to be deleterious. 39 The r 2 between rs2234253 and rs7748513 in WHI-SHARe AA participants was 0.41. Upon adjustment for rs7748513, the CRP association with rs2234253 was greatly attenuated but still nominally significant (beta ¼ 0.063 5 0.030; p ¼ 0.04). Haplotype analysis showed that the minor allele of rs2234253 (the p.Lys96 variant) is only present in combination with the African G variant of rs7748513; thus, these two SNPs define three common TREM2 haplotypes that are associated with lower (A/Thr), intermediate (G/Thr), and higher (G/Lys) CRP (Table 5) .
To validate the newly discovered TREM2 CRP association in an independent sample of AA individuals, we performed association analysis for rs7748513 and rs2234253 in 6,272 AA men and women from the CARe GWAS consortium. rs7748513 met the significance threshold for association (0.044 5 0.021 increased ln-CRP; p ¼ 0.037), whereas rs2234253 did not (0.053 5 0.031 increased ln-CRP; p ¼ 0.09). When stratified by sex, the rs7748513 association was present among the 3,787 AA women (beta ¼ 0.070; p ¼ 0.011), but not among the 2,488 AA men (beta ¼ 0.0013; p ¼ 0.97). The p value for interaction between TREM2 rs7748513 genotype and sex in CARe AA individuals was 0.06. Because the association between the TREM2 genotype and CRP appears to be confined to women, we meta-analyzed the WHI-SHARe AA discovery results with the CARe AA validation results in women only. The combined discovery and validation p values were 1 3 10 À10 for rs7748513 and 3 3 10 À6 for rs2234253.
We further assessed the association between TREM2 and CRP in the 3,548 WHI-SHARe HA women, in whom the frequency of the rs7748513 G allele was 0.08. In HA women, the rs7748513 G allele was associated with 0.095 natural-log units higher CRP (p ¼ 0.035), whereas the rs2234253 coding variant showed a nonsignificant trend in the same direction (beta ¼ 0.168; p ¼ 0.12). In 5,656 white ARIC study participants, there was no evidence of association between CRP and rs7748513 (MAF ¼ 0.04; p ¼ 0.96). When stratified by sex, the results for rs7748513 were somewhat stronger, though not statistically significant, in white women (0.0614 higher ln-CRP in 3,046 white women [p ¼ 0.18]) compared to men (0.00177 higher ln-CRP in 2,694 white men [p ¼ 0.97]).
Given that TREM-2 has been associated with autoimmune and inflammatory diseases 40 and that autoimmune diseases (MIM 109100) are more prevalent in women, we stratified the WHI-SHARe AA results by autoimmunedisease status. In the 2,505 women reporting a history of autoimmune disease, the rs7748513 G allele was associated with 0.132 natural-log units higher CRP (p ¼ 3.8 3 10 À4 ).
In the 5,732 women without autoimmune disease, the rs7748513 G allele was associated with 0.083 natural-log units higher CRP (p ¼ 2.2 3 10 À5 ). The p value for interaction was 0.31.
To assess the effect of the TREM2 rs7748513 G allele on gene expression, we queried a human monocyte eQTL database derived from 1,467 European subjects. 38 Monocytes are one of the white blood cell subtypes that express the TREM receptors on their surface. We did not find evidence for a cis-eQTL in TREM2. Nonetheless, a ciseQTL was observed in this region of chromosome 6 for association with monocyte mRNA levels of TREML4 (MIM 614664) (p ¼ 8.43 3 10 À6 ), which is located 68 kb downstream of rs7748513 and is between TREM2 and TREM1. No additional significant cis-or trans-effects were observed for TREM2 rs7748513 with the use of a p threshold of <10 À5 .
Assessment of Other Previously Discovered WBC-Associated Loci in AA Individuals
Eighteen CRP loci have been identified previously in European or Japanese GWASs. [20] [21] [22] [23] Table S1 shows the association results of the originally reported index SNP from these loci in our WHI-SHARe AA and HA populations. In AA individuals, seven loci met the strict Bonferroni-corrected 
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For each locus, the lead SNP with the smallest p values among the genotyped or imputed SNPs is indicated. Effect size represents the effect of a minor allele on natural-log-transformed CRP. Positions of the SNPs were derived from dbSNP build 136. 
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For each locus, the lead SNP with the smallest p values among the genotyped or imputed SNPs is indicated. Effect size represents the effect of a minor allele on natural-log-transformed CRP. Positions of the SNPs were derived from dbSNP build 136. Novel CRP associations are shown in bold.
significance threshold (p < 0.0028), whereas 12 of 16 loci tested (75%) had p < 0.05 and the same direction of effect. Notably, in several instances (HNF1A, IL6R, HNF4A , the allele associated with higher CRP is more common among Africans than among Europeans. In HA individuals, six loci met the Bonferroni significance criteria for replication, whereas 9 of 13 (69%) were nominally associated with CRP at p < 0.05 and showed consistent direction of effect. Eight (CRP, APOC1, LEPR, IL6R, GCKR, NLRP3, IL1F10, and HNF4A) of 12 loci (67%) showed consistency of CRP association across white, AA, and HA individuals.
Discussion
In the largest reported GWAS of CRP in United States minority populations, we have identified and validated in chromosomal region 6p21 an African TREM2 variant associated with higher CRP in AA women. We also demonstrate in AA individuals a strong admixture association signal due to several polymorphisms (located within the CRP region) that are independently associated with CRP. As previously reported, the most significant of these is specific to African ancestral populations and is associated with higher CRP. Most loci (CRP, LEPR, IL1RN, IL6R, GCKR, NLRP3, HNF1A, HNF4A, and APOC1) previously associated with CRP through GWASs of European populations showed consistent patterns of association with CRP in AA and HA individuals. Of the CRP loci identified through GWASs of European, Japanese, or AA individuals, the index SNPs at CRP, IL6R, HNF1A, GCKR, TREM2, RORA, and HNF4A showed differences in allele frequency between ancestral populations; the African ancestral allele generally was associated with higher CRP.
TREM2 Is a Genetic Locus Associated with CRP in AA Women TREMs belong to a family of membrane-bound and soluble receptors encoded by a gene cluster centromeric to the HLA region on human chromosome 6. 40,41 TREM-1 activates neutrophils and monocytes in response to bacterial and fungal pathogens by signaling through the adaptor protein DAP12, triggering secretion of proinflammatory chemokines and cytokines, neutrophil degranulation, and phagocytosis. TREM-2 is present on macrophages, microglia, and monocyte-derived dendritic cells and is thought to negatively regulate macrophage cytokine production and autoimmunity. TREM-2 deficiency in humans (Nasu-Hakola syndrome [MIM 221770]) is characterized by bone cysts and CNS demyelination, which leads to dementia. 42 TREM-1 and TREM-2 are also expressed constitutively by hepatic macrophages and endothelial cells, and they might have an important role in the inflammatory response to bacterial infection. 43 Given the influence of The following abbreviations are used: YRI, Yoruba in Ibadan, Nigeria; CEU, Utah residents with ancestry from northern and western Europe from the CEPH collection; CHB, Han Chinese in Beijing, China; PC, principal component; and N/A, not available.
gender and ethnicity on CRP, it is noteworthy that the TREM2 variant associated with higher CRP is common only among African ancestral populations and appears to be confined to women only. Why this association would be sex specific is unclear. All WHI-SHARe participants were postmenopausal, and there was no evidence of interaction between exogenous sex-hormone use and the TREM2 genotype on CRP (data not shown). Further evaluation of the TREM2 genotype in larger samples of AA men and women is needed for confirming the gender specificity of the CRP effect.
Allelic Heterogeneity at the CRP Locus Allelic heterogeneity at the CRP locus has been previously demonstrated in single-cohort studies of EA and AA adults. 15 Of the common CRP SNPs identified by resequencing, several in the CRP promoter region are strongly associated with CRP levels and are correlated with the independently associated CRP index SNPs observed in WHI-SHARe. The CRP-increasing allele of rs16827466 is in LD with a common African CRP promoter haplotype tagged by rs3093058 (CRP-790 T allele), associated with increased basal CRP transcriptional activity in human hepatocytes. 15 By contrast, rs7553007 is in LD with a haplotype tagged by rs1205, located in the CRP 3 0 flanking region (CRP-3872). The same CRP-lowering haplotype tagged by rs1205 has been associated with lower CRP in AA and HA individuals 44 and with lower promoter activity. 15 In Europeans, rs1205 is in perfect LD (r 2 ¼ 1.0) with the index SNP rs2794520 at the 1q23 CRP locus previously reported in European GWASs. 21 The CRPlowering allele of rs1205 (or rs287994520) is less common in African populations than in Europeans and Hispanics (see Table S1 ). A third CRP-lowering SNP rs1800947 (CRP-2667) is a synonymous coding variant 15 that is present in European, Asian, and Hispanic, but not African, populations. 15, 44 Thus, interpopulation differences in CRP might be attributable to allele-frequency differences at several CRP SNPs, in which the allele associated with lower CRP levels is more frequent in EA or HA individuals than in AA individuals.
Population Genetic Analysis of the 1q23 Region Containing CRP and DARC The admixture mapping evidence in chromosomal region 1q23 suggests that this region harbors CRP-associated alleles, which occur at disparate frequencies between the European and African ancestral populations. Indeed, the CRP-increasing variant rs16827466 occurs almost exclusively in Africans, whereas alleles at rs16827466, rs7553007, and rs2808634 also exhibit frequency difference between the HapMap CEU and YRI populations. It is therefore reasonable to ask whether this pattern of divergence is influenced by evolutionary forces other than random drift. CRP is located~500 kb downstream of DARC, a locus that represents a target of natural selection. 45, 46 In Africa, homozygosity for a null allele (FY*O or rs2814778) is known to confer resistance to vivax malaria; the null allele is essentially fixed in sub-Saharan African populations but is virtually absent in other parts of the world. Could some of the CRP alleles have reached higher frequency in Africans by hitchhiking on the FY*O haplotypes? Contradicting this hypothesis, we found that LD between CRP and DARC is low in both HapMap CEU and YRI populations ( Figure S4 ). In contrast to FY*O, both rs7553007 and rs2808634 are polymorphic in HapMap CEU, YRI, East Asian, and other populations, suggesting that these variations predate the adaptive selection of the FY*O allelẽ 10,000 years ago. 47 These observations suggest that evolution at the CRP locus is most likely independent of that at the DARC locus. Although methods based on homozygosity or Fst do not present unambiguous signature of selection in CRP in any continental population, the possibility of adaptive evolution cannot be excluded. This is because most existing methods for detecting signature of selection focus on classic sweeps, in which a beneficial mutation is rapidly driven toward fixation. 48 Variation in CRP shows a more complex pattern: multiple variants influence the phenotype. Additionally, the complex population genetic structure within Africa and the admixing history of AA individuals require selection studies for carefully modeling the demographic history. Although the strong correlation between CRP and obesity accounts for some of the differences in CRP across populations, 12, 15 genetic factors also appear to contribute to the interethnic phenotypic differences. Intriguingly, almost all CRP-increasing variants occur at a higher frequency in African populations than they do in European populations (see Table S1 ).This is consistent with a model in which standing variation is subjected to population-specific directional selection: CRP-increasing variants become adaptive in Africans while CRP-decreasing variants spread in Europeans. 
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CRP Genetic Loci and the Role of Inflammation in Cardiovascular and Metabolic Disease
Of the approximately 20 loci associated with CRP, many of these genes involve pathways related to either innate immunity (e.g., CRP, IL6R, IL6, NLRP3, IL1RN, IRF1, and TREM2) or lipid and glucose metabolism (e.g., APOC1, HNF1A, LEPR, GCKR, HNF4A, RORA, and PTPN2), highlighting the connection between inflammation and metabolic dysregulation. Interethnic differences in CRP and the underlying genetic architecture of CRP have potential implications for cardiovascular-risk stratification, prediction, and treatment, such as statin eligibility. AA individuals have higher CVD risk than do non-Hispanic whites despite higher high-density lipoprotein (HDL) cholesterol and lower triglyceride levels. [49] [50] [51] Chronic low-grade inflammation might contribute to increased cardiovascular-disease risk and other health disparities among these minority United States populations. 11 The metabolic syndrome paradoxically has a lower prevalence in AA individuals than in EA individuals, but there is a greater difference in CRP among AA individuals with and without the metabolic syndrome than there is among EA individuals with and without metabolic syndrome.
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CRP biosynthesis is largely under the control of IL-6, which together with IL-1b activates transcription factors that induce CRP transcription. The IL-6-receptor p.Asp358Ala polymorphism encoded by IL6R rs8192284 is known to dampen the inflammatory effect of IL-6 and lower CRP and has been associated with a lower risk of coronary heart disease (CHD). 53 These results suggest not only a causal role of IL-6-receptor signaling in CHD pathogenesis but also that IL-6-receptor blockade with agents such as tocilizumab might provide a novel therapeutic approach to CHD prevention. Notably, the cardioprotective IL-6-receptor p.Asp358Ala variant is considerably less common among AA individuals than it is among whites and HA individuals (Table S1 ). Therefore, IL-6-receptor blockade might represent a particularly important therapeutic target for CHD prevention in AA individuals.
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